Jinxin Fertility Group Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Jinxin Fertility Group wird ein jährliches Gewinn- und Umsatzwachstum von 19.4% bzw. 10.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 19.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5.1% betragen.
Wichtige Informationen
19.4%
Wachstumsrate der Gewinne
19.3%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 18.3% |
| Wachstumsrate der Einnahmen | 10.8% |
| Zukünftige Eigenkapitalrendite | 5.1% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 21 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Is Now The Time To Look At Buying Jinxin Fertility Group Limited (HKG:1951)?
Nov 13
Jinxin Fertility Group Limited's (HKG:1951) 30% Jump Shows Its Popularity With Investors
Sep 27Is Jinxin Fertility Group (HKG:1951) A Risky Investment?
Sep 02Jinxin Fertility Group (HKG:1951) Will Want To Turn Around Its Return Trends
May 30After Leaping 25% Jinxin Fertility Group Limited (HKG:1951) Shares Are Not Flying Under The Radar
May 13These 4 Measures Indicate That Jinxin Fertility Group (HKG:1951) Is Using Debt Reasonably Well
May 05What Is Jinxin Fertility Group Limited's (HKG:1951) Share Price Doing?
Mar 12Capital Allocation Trends At Jinxin Fertility Group (HKG:1951) Aren't Ideal
Feb 14With Jinxin Fertility Group Limited (HKG:1951) It Looks Like You'll Get What You Pay For
Dec 25What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Dec 08Jinxin Fertility Group (HKG:1951) Is Reinvesting At Lower Rates Of Return
Oct 22Jinxin Fertility Group (HKG:1951) Takes On Some Risk With Its Use Of Debt
Sep 20What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Sep 04Are Investors Undervaluing Jinxin Fertility Group Limited (HKG:1951) By 43%?
May 30Is Now The Time To Look At Buying Jinxin Fertility Group Limited (HKG:1951)?
Apr 20An Intrinsic Calculation For Jinxin Fertility Group Limited (HKG:1951) Suggests It's 34% Undervalued
Feb 27Is There Now An Opportunity In Jinxin Fertility Group Limited (HKG:1951)?
Jan 09Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Dec 11Some Investors May Be Worried About Jinxin Fertility Group's (HKG:1951) Returns On Capital
Nov 28Jinxin Fertility Group Limited (HKG:1951) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 03Is Jinxin Fertility Group Limited (HKG:1951) Potentially Undervalued?
Oct 04Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Sep 07Is There Now An Opportunity In Jinxin Fertility Group Limited (HKG:1951)?
Jun 06Jinxin Fertility Group (HKG:1951) Has A Rock Solid Balance Sheet
Apr 05What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Feb 25The Returns On Capital At Jinxin Fertility Group (HKG:1951) Don't Inspire Confidence
Jan 21Why Jinxin Fertility Group Limited (HKG:1951) Could Be Worth Watching
Nov 15Jinxin Fertility Group (HKG:1951) Seems To Use Debt Quite Sensibly
Oct 11Returns On Capital At Jinxin Fertility Group (HKG:1951) Paint A Concerning Picture
Sep 28Jinxin Fertility Group Limited's (HKG:1951) Intrinsic Value Is Potentially 44% Above Its Share Price
Sep 15Should You Think About Buying Jinxin Fertility Group Limited (HKG:1951) Now?
Jul 20Is Jinxin Fertility Group (HKG:1951) A Risky Investment?
Jun 29Are Jinxin Fertility Group Limited (HKG:1951) Investors Paying Above The Intrinsic Value?
Jun 09What Type Of Shareholders Make Up Jinxin Fertility Group Limited's (HKG:1951) Share Registry?
Mar 15Are Jinxin Fertility Group Limited (HKG:1951) Investors Paying Above The Intrinsic Value?
Feb 22If You Had Bought Jinxin Fertility Group (HKG:1951) Stock A Year Ago, You Could Pocket A 68% Gain Today
Feb 04Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 3,910 | 558 | 686 | 975 | 14 |
| 12/31/2025 | 3,505 | 476 | 682 | 886 | 17 |
| 12/31/2024 | 3,049 | 406 | 385 | 724 | 12 |
| 6/30/2024 | 2,899 | 311 | 560 | 731 | N/A |
| 3/31/2024 | 2,844 | 328 | 536 | 708 | N/A |
| 12/31/2023 | 2,789 | 345 | 511 | 684 | N/A |
| 9/30/2023 | 2,675 | 250 | 495 | 645 | N/A |
| 6/30/2023 | 2,560 | 155 | 480 | 606 | N/A |
| 3/31/2023 | 2,462 | 138 | 31 | 574 | N/A |
| 12/31/2022 | 2,364 | 121 | -418 | 542 | N/A |
| 9/30/2022 | 2,241 | 248 | -479 | 492 | N/A |
| 6/30/2022 | 2,118 | 374 | -541 | 442 | N/A |
| 3/31/2022 | 1,978 | 357 | -139 | 393 | N/A |
| 12/31/2021 | 1,839 | 340 | 264 | 343 | N/A |
| 9/30/2021 | 1,756 | 316 | 190 | 374 | N/A |
| 6/30/2021 | 1,674 | 291 | 117 | 405 | N/A |
| 3/31/2021 | 1,550 | 271 | 51 | 356 | N/A |
| 12/31/2020 | 1,426 | 252 | -15 | 308 | N/A |
| 9/30/2020 | 1,448 | 304 | -21 | 295 | N/A |
| 6/30/2020 | 1,469 | 356 | -27 | 281 | N/A |
| 3/31/2020 | 1,559 | 383 | 74 | 367 | N/A |
| 12/31/2019 | 1,648 | 410 | 175 | 453 | N/A |
| 9/30/2019 | 1,475 | 339 | 302 | 457 | N/A |
| 6/30/2019 | 1,301 | 269 | 428 | 461 | N/A |
| 3/31/2019 | 1,112 | 218 | 382 | 409 | N/A |
| 12/31/2018 | 922 | 167 | 335 | 356 | N/A |
| 12/31/2017 | 663 | 99 | N/A | 48 | N/A |
| 12/31/2016 | 346 | 88 | N/A | 109 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: 1951Das prognostizierte Gewinnwachstum (19.4% pro Jahr) liegt über der Sparquote (2.3%).
Ertrag vs. Markt: 1951Die Erträge des Unternehmens (19.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (11.6% pro Jahr).
Hohe Wachstumserträge: 1951Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: 1951Die Einnahmen des Unternehmens (10.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (7.8% pro Jahr).
Hohe Wachstumseinnahmen: 1951Die Einnahmen des Unternehmens (10.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: 1951Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5.1%).